| Record ID | marc_loc_2016/BooksAll.2016.part24.utf8:133235312:979 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part24.utf8:133235312:979?format=raw |
LEADER: 00979nam a2200265 a 4500
001 95068327
003 DLC
005 19950815141817.4
008 950316s1995 dcu b f000 0 eng
010 $a 95068327
020 $a0309052793
040 $aDLC$cDLC
050 00 $aRC848.H44$bR48 1995
082 00 $a616.3/623061$220
245 00 $aReview of the Fialuridine (FIAU) clinical trials /$cFrederick J. Manning and Morton Swartz, editors.
260 $aWashington, DC :$bNational Academy Press,$c1995.
300 $aix, 269 p. ;$c29 cm.
500 $a"Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Division of Health Sciences Policy, Institute of Medicine".
504 $aIncludes bibliographical references (p. 165-177).
650 0 $aHepatitis B$xChemotherapy$xEvaluation.
650 0 $aFialuridine$xTesting.
650 0 $aFiacitabine$xTesting.
650 0 $aClinical trials$xSafety measures.
700 10 $aManning, Frederick J.
700 10 $aSwartz, Morton N.